Introduction
Tobacco use is the most significant preventable cause of morbidity and mortality, with ~5 million deaths caused by direct tobacco use and >600,000 deaths due to secondhand smoke worldwide every year. Cigarette smoking (CS) is the most common form of tobacco consumption in most countries. 1 Due to the well-known detrimental effects of long-term cigarette smoking (LTCS) on health, many countries have implemented intensified tobacco control efforts which resulted in a reduced prevalence of daily smoking since 1980. However, in many countries, the number of smokers is actually increasing, and there are preliminary indications that global prevalence among men will increase further in the next years. 1, 2 LTCS represents an important risk factor for cardiac infarction and stroke and the central risk factor for the development of a bronchial carcinoma, smoking-associated interstitial lung fibrosis, and chronic obstructive pulmonary disease (COPD). About 20% of smokers develop a COPD which is actually ranking as the fifth most common cause of mortality worldwide. 2 Also, smoking cessation does not reverse the progression of COPD in patients, indicating that smoking is an important cause, but not the only driver of disease progression in COPD patients. COPD is characterized not only by the destruction of lung tissue but also by a systemic inflammation. It is suggested that a sustained systemic inflammation develops during LTCS, resulting in COPD and its comorbidities such as muscle wasting, vascular diseases, heart diseases, and stroke. 3, 4 The purpose of this review was to summarize the current knowledge about cigarette smoke-induced inflammation. Studies about the immunological effects of acute smoking, LTCS, secondhand CS, and COPD patients were included. In order to describe the molecular mechanisms of smoke-induced inflammation, in vitro studies and animal studies of smoke exposure were also included. The purpose of the second part of the review was to describe the current knowledge of the immuneregulating systemic and local potentials of regular exercise training after smoke-induced inflammation.
Methods
We searched various electronic databases such as PubMed, Web of Sciences, and Cochrane Library for English language articles without any date restriction. Our review focused on the effects of CS-induced inflammation on different organs (such as brain, lung, heart, muscle, etc) as well as on immune-regulating effects of exercise which may counteract CS-induced inflammation. Search terms on PubMed (abstract and/or title) as shown in Table 1 were used. After careful review of titles and abstracts, it was decided whether the full-text will further be analyzed and consequently considered in this review.
From CS to inflammation
The mechanisms of initiation and persistence of cigarette smoke (CS)-induced inflammation are not completely understood. CS comprises about 4,000 chemicals, including several carcinogens. Toxicologic studies have revealed a multitude of immunomodulatory chemicals and gas. 5 Consequently, LTCS results in repetitive inflammatory insults leading to a chronic and progressive activation of the immune system accompanied by an abnormal inflammatory response of the airways to various noxious gases and particles. 6, 7 On the one hand, smoke pollutants cross through the alveolus-capillary interface and spread directly through the systemic bloodstream targeting different organs. 7 At this point, they might be recognized by receptors of the innate immune system which initiate inflammatory signaling cascades via NF-κB activation. 5 On the other hand, inflammatory processes are suggested to originate in the pulmonary system. Here, toxic substances disturb the barrier function of the respiratory epithelium and impact both innate and adaptive host defense mechanisms. This primarily local inflammatory processes spillover into the circulation leading to inflammatory and degenerative processes in other organs and tissues. Thus, inflammation is suggested to be the main driver of the central comorbidities.
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Table 1 Search terms on PubMed
Focus CS-induced inflammation
Effects of CS on inflammatory processes in respiratory tract and lungs CS comprises various components that damage the pulmonary epithelium. LTCS has been shown to injure the cell membranes and alter the mucosal permeability. 9 Cellular damage is followed by a compromised immune status, allowing opportunistic pathogens to cause infections that might amplify the inflammatory processes. Furthermore, components of the innate and adaptive immune system are chronically activated. Analysis of bronchoalveolar lavage fluid and breath condensate provides evidence that even acute exposure to cigarette smoke results in oxidative stress and tissue damage as suggested by increased products of lipid peroxidation and degradation products of extracellular matrix proteins. 5 In bronchoalveolar lavage (BAL) of long-term smokers, an increase of interleukin (IL)-1β, IL-6, IL-8, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α, regulated on activation, normal T-cell expressed and secreted (RANTES), tumor necrosis factor (TNF)-α, IL-12 (p40), and IL-17 was found. 10, 11 Recent data suggest that airway epithelial cells (AECs) which represent a first line of defense against inhaled toxicants have altered inflammatory signaling in response to CS exposure. These cells were shown to upregulate cytokine expression and expression of matrix metalloproteases (MMPs) via extracellular signal-regulated kinase (ERK) signaling and increased p38 activation. Furthermore, AECs show characteristics of cellular damage and cell death consequently leading to the release of damage-associated molecular patterns (DAMPs) into the extracellular space. DAMPs target pattern recognition receptors such as Toll-like receptor (TLR). TLRs are found on both immune and epithelial cells throughout the pulmonary system. TLRs recognize patterns of bacteria, fungi, and viruses, and the levels of TLR4 are elevated in cigarette smokers with COPD. After TLR activation, the NF-kB pathway is induced followed by the secretion of a variety of pro-inflammatory cytokines. 12 In particular, MMP-9 and -12, surfactant protein D, and IL-1, IL-6, IL-8, and IL-17 have been found in higher quantities in the lungs of long-term smokers with the ongoing inflammation. 10 In parallel, immune cells, macrophages, neutrophils, dendritic cells, and lymphocytes migrate into the pulmonary system. [11] [12] [13] Alveolar macrophages might play a key role in the pathogenesis of inflammation in lungs. These cells produce increased levels of MMPs, such as MMP-1, MMP-2, MMP-9, MMP-12, and MMP-14, after smoke exposure (Figure 1 ). 10 
Specific role of lymphocytes
Currently, it is discussed that lymphocytes might play a crucial role in inflammatory pathogenesis. Specifically, CD8 + T lymphocytes have been shown to be dramatically increased in the lungs of heavy smokers accompanied by a shift toward a type 1 profile. This immune cell subtype produces large amounts of interferon-γ and releases perforins and granzyme. Also B lymphocytes are activated, and it is suggested that their antigen-specific responses could turn against self-epitopes, partly because of impaired tolerance. In parallel, smoke exposure led to an accumulation of forkhead-box-protein (FOX)P31 T-regulatory cells (Tregs) in lungs of mice which might participate in controlling inflammatory processes. 14 Accordingly, LTCS seems to alter the pulmonary immune equilibrium which turns into a chronic activated, immunosuppressed condition. 15 
Effects of LTCS on systemic inflammation
Every smoked cigarette seems to elicit a slight increase of oxidative stress and inflammation in blood indicated by an increase of thiobarbituric acid-reactive substances, neutrophil elastase, leukotrienes, and neutrophils after acute CS in humans. 5 Chronically, most studies agree that LCTS induces an increase in the numbers of circulating neutrophils, macrophages, and lymphocytes. These cells show several inflammatory characteristics such as expression of activation markers and adhesion molecules which might mediate the migration into the bronchoalveolar system or other tissues. 8, 16 On the molecular levels, LTCS induces a systemic low-grade inflammation characterized by chronically elevated levels of various markers for inflammation, tissue deterioration, and coagulation, such as C-reactive protein (CRP), TNF-α, von Willebrand factor (vWF), tissue inhibitor of metalloproteinases-1, factor VII, and fibrinogen. Blood is suggested to be a transit way for transfer and spreading these molecules which target other organs and tissues. 17, 18 Effects of CS on the vascular endothelium
The particulate phase of CS consists of lipophilic components, which can pass the lipid bilayer of respiratory membranes; therefore, the damage is not limited to the lung tissue as it can also affect the vascular system. 19 The integrity of endothelial cells (ECs) is essential, since it preserves vascular homeostasis, allows continuous adjustment of vascular tone and maintenance of blood fluidity, and regulates leukocyte traffic. 20 Components of CS are toxic for ECs, and LTCS can lead to dysfunction of ECs, 21 an early hallmark of atherosclerosis. 22 Endothelial dysfunction is characterized by an imbalance of vasoconstrictors and vasodilators, aberrant interaction between endothelial and immune cells, and higher expression of adhesion molecules. 23 Dysfunctional ECs express lower levels of prostacyclin, thrombomodulin, 
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Madani et al tissue plasminogen activator (tPA), and NO while expression levels of endothelin-1, angiotensin II, plasminogen activator inhibitor-1 (PAI-1), and vWF are increased. 20 Therefore, CS favors inflammatory processes in ECs and is a huge risk factor for the development of atherosclerosis and cardiovascular diseases (CVDs). 22 In vitro studies in ECs demonstrate that CS induces cell injury in a dose-and time-dependent manner 24 which can lead to apoptosis, 25 autophagic cell death, 26 and necrosis. 27 Different mechanisms are responsible for the induction of apoptosis in ECs induced by CS. One study showed that aqueous filtrates of CS lead to mitochondrial membrane depolarization, representing an early step in the apoptotic pathway. 22 The negative influence of CS on apoptotic-related genes has also been reported. For example, CS decreases p53 and Bcl-2 expression, 28 disrupts the vascular endothelial growth factor (VEGF), and fluid shear stress-mediated VEGFR2/phosphoinositide 3-kinase (PI3K) signaling pathway 29 and reduces the cytochrome-c oxidase II expression through aberrant DNA methylation. 25 Vascular damage through excessive apoptosis was also shown to be initiated by a p53-independent caspase-3 activating pathway. 30 EC injury may also be mediated through protein carbonylation which is caused by reactive species in CS. 31 Recruitment of leukocytes to the inflammation site happens by cytokine signaling, MMP-1 and MMP-9 upregulation, and through cell adhesion of immune cells to ECs. 32 
Potential mechanisms of atherogenesis
The underlying mechanism of atherogenesis of ECs induced by CS is not fully understood yet. 33 So far, CS-induced inflammation-related responses have been described in experimental studies in vitro. CS led to phosphorylation of various mitogen-activated protein kinases (MAPK), like p38, 34 c-Jun N-terminal kinase (JNK), and ERK. 34, 35 The expression levels of osteopontin, 35 E-selectin, intercellular cell adhesion molecule-1 (ICAM-1), 36 and IL-8 37 were also induced by CS. Furthermore, CS induced nicotinamide adenine dinucleotide phosphate (NAD(P)H)-oxidase-derived 
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Exercise and cigarette smoke-induced inflammation H 2 O 2 generation, 38 upregulated fractalkine (CX3CL1), increased IL-13Rα2 through the activation of protein kinase A-cAMP response element-binding protein (PKA-CREB) pathway, 39 increased cyclooxygenase-2 (COX-2) expression through nuclear β-catenin accumulation due to the activation of epidermal growth factor receptor (EGFR)/Akt/glycogen synthase kinase-3β pathways. 40 One cell culture study demonstrated that ECs treated with CS for 72 hours expressed only minor differences in various cytokines on mRNA level. 41 CS promotes endothelial dysfunction as well by impairing endothelium-dependent relaxation, presumably through suppression of NO production 42 and CS-low-density lipoprotein (CS-LDL). 43 Cell culture studies proved that exposure of ECs to CS impaired the VEGF-induced EC migration 44, 45 and tube formation, explaining the negative effect of CS on vessel growth and endothelial function. 45 
Effect of smoking on the cardiac tissue
Persistent inflammation is an important factor in the development of CVD. 46 Since CS promotes inflammation 47 and injures the cardiovascular system chronically, it is not surprising that the risk for CVD is twice as high in smokers than in nonsmokers. 48 Toxic effects of CS on the myocardium have been proved experimentally as well as clinically, 15 but whether smoking is a direct or indirect cause of CVD still needs to be proved. 49 It is somehow remarkable that even secondhand smoke has the ability to increase the risk for CVD to as high as 30%. 48, [50] [51] [52] [53] [54] Secondhand smoking combined with an unhealthy lifestyle was shown to reduce the ability of the heart adapt sensitively to sidestream smoke in a murine model. 48 Furthermore, in nonsmoking humans, secondhand smoking increased WBC count immediately as well as CRP levels 18 h after exposure. Both of these are markers for inflammation and have been linked to a higher incidence of CVD. 50 The situation for smokers is worse. Active smoking increases cardiac afterload, promotes a pro-thrombotic status, reduces fibrinolysis, changes the profile of circulating lipids, 48 promotes neutrophil infiltration in the myocardium, 55 alters T-cell function, 56 and causes DNA adducts in the myocardium. 57 CS leads to the production of reactive oxygen species (ROS) which initiate ROS-sensitive signal transduction pathways, such as MAPKs, and various transcription factors, including NF-kB 15 resulting in an aberrant cytokine profile. [58] [59] [60] Gene analysis of the hearts of mice revealed an upregulation of the xenobiotic-metabolizing enzyme cytochrome P-450 1A1 and a downregulation of PAI-1, representing a key gene involved in fibrinolysis. 61 Taken together, all mentioned factors are suggested to increase the risk for several diseases of the cardiovascular system also in human smokers. 62 
Effects of LTCS on muscle tissue
Human smokers tend to have a lower BMI while central or abdominal obesity seems to be increased. Thus, the weight loss associated with tobacco smoking may be due to loss of lean mass rather than fat. 63 It is suggested that inflammation and oxidation of proteins are two main contributors to the development of skeletal muscle loss and dysfunction observed in LTCS and COPD patients. 63 Structurally, LTCS leads to a reduced percentage of type I fiber, a lower muscle fiber cross-sectional area, an increased glycolytic enzymatic activity, and decreased muscle oxidative activity. 8, 63, 64 Mice chronically exposed to cigarette smoke tend to a reduced muscle capillary to fiber ratio along with decreased VEGF, lowered endothelial and neuronal nitrite oxide synthase activities in muscle vessels, and increased inflammatory activity indicated by an increased mRNA expression of TNF-α and IL-1β. 8, 64, 65 The role of numerous cell signaling pathways in the development of skeletal muscle atrophy, a key element of muscle dysfunction in long-term cigarette smokers and COPD patients, has been investigated. 65 In general, atrophy occurs when protein degradation exceeds protein synthesis. With regard to protein degradation, the ubiquitin proteasome system (UPS) seems to have an important role during LTCS. In smoke-exposed mice, an increased ubiquitination of target proteins was demonstrated, which was indicated by the increased activities of the E3 ubiquitin ligases atrogin-1 and muscle RING finger protein-1 (MuRF1). 66 In parallel, key factors that induce protein synthesis such as insulin-like growth factor 1 (IGF-1), are reduced followed by a lower activation of anabolic signaling pathways such as protein kinase B (Akt) and rapamycin (mTOR) pathways. All the mentioned pathways interact with inflammatory signaling molecules such as TNF-α turning protein balance toward an enhanced degradation leading to muscle wasting.
63,66
Effects of LTCS on brain inflammation
Atherosclerosis and vascular brain lesions share similar pathological features such as oxidative stress and increased inflammation. 67 Oxidative stress, for example, plays a decisive role in the pathogenesis of ischemic brain injury. 68 It is not surprising that direct and secondhand CS are associated with various cerebrovascular-related diseases, 32 in particular, smoking is a risk factor for stroke. 69 Likewise to the effects of CS on endothelial cells, 70 higher expression of VEGF, ICAM-1, IL-8, and nuclear factor (erythroid-derived 2)-like 2 was also observed in cultured brain ECs. 71 Furthermore, it was shown that CS extracts induced heme oxygenase-1 (HO-1) expression mediated by phosphatidylcholine phospholipase C/protein kinase Cδ/ NADPH oxidase-dependent platelet-derived growth factor receptor (PDGFR)/PI3K/Akt pathway. 19 Higher HO-1 expression was shown to exacerbate early brain injury during intracerebral hemorrhagic stroke. 72 Endothelin-1 levels decreased in rat brains exposed to CS, implying that endothelin-1 may contribute to the hemodynamic response to chronic CS. 73 
Effects on brain ECs
Moreover, animal experiments proved that CS negatively affected endothelial tight junctions 71 and downregulated the activity of Na-K-2Cl cotransporter in brain ECs. The latter could possibly contribute to an increase in extracellular K + . Therefore, CS may exacerbate ischemic cellular damage and hinder recovery from ischemic damage. In addition, accumulation of extracellular fluid K + is a risk factor for cellular edema in astrocytes and neurons and could impair neuronal conduction after stroke. 74 Increased blood viscosity due to CS impairs the blood flow and risks the integrity of the brain microvasculature. 32 On top of everything, CS negatively affects the viability of the blood-brain barrier (BBB). Taken together, CS and hemodynamic impairments contribute synergistically to vascular inflammation and BBB damage. 32 Inflammation of brain cells due to CS was also confirmed in various in vivo studies using mouse and rat models. Inflammation and cell death processes in the brain are often characterized by alterations of the neuroproteome. [73] [74] [75] Mice exposed to secondhand CS, showed higher levels of ROS, induction of lipid peroxidation, activation of the transcription factors NF-kB and activator protein-1, as well as activation of MAPK, including JNK, ERK, and p38, and COX-2 in various regions of the brain. 69 Furthermore, secondhand CS altered enzymatic antioxidant defenses by reducing superoxide dismutase as well as catalase and increasing glutathione S-transferase activity in rat brains. Moreover, rats exposed to secondhand CS showed increased proteolytic degradation of αII-spectrin through caspase-3 and dephosphorylation of phosphoprotein enriched in astrocytes-15, both indicating apoptotic cell death. 
Immune-regulating effects of exercise training
Exercise training has been shown to be an effective nonpharmacological treatment strategy in pulmonary diseases and systemic lung diseases. Furthermore, regular exercise has been shown to increase patients' strength, endurance capacity, quality-of-life scores, and symptoms of fatigue and dyspnea. 76 Thus, the beneficial effects of exercise training in pulmonary rehabilitation are well established. Recent studies provided evidence that regular and moderate exercise exerts protective effects against smoke-induced lung disease due to its anti-inflammatory effects. 64, 77 Anti-inflammatory effects of exercise Exercise training exerts its immune-regulating effects by activating anti-inflammatory signaling pathways. 78, 79 Contracting skeletal muscle produces and secretes the antiinflammatory myokine IL-6 during an acute bout of exercise, which evokes a subsequent rise in circulating levels of IL-6 followed by an ensuing increase in systemic levels of the anti-inflammatory cytokines IL-10 and IL-1RA.
77-79 IL-10, which is mainly produced by Tregs, reduces tissue damage caused by inflammation and is known to diminish the adaptive immune response. [80] [81] [82] Complementarily, IL-1RA is capable to limit the effects of the pro-inflammatory cytokine IL-1β and therefore serves as an important contributor to exercise-induced anti-inflammatory state. 79 Besides, exercise-induced systemic elevations of cortisol, adrenalin, and IL-6 inhibit the secretion of pro-inflammatory TNF-α by monocytes. 78, 82, 83 Moreover, after an acute bout of strenuous prolonged exercise, a reduced expression of TLRs on monocytes can be observed, which results in subsequent inhibition of pro-inflammatory cytokines and promotes the expression of costimulatory molecules and major histocompatibility complex. 83, 84 CD14 low CD16 + monocytes are characterized by heightened TLR-4 expression and thereby associated with pro-inflammatory properties. 85 Regular exercise lowers the ratio of pro-inflammatory monocytes (CD14 low CD16 + ) to classical monocytes (CD14 hi CD16 -). 86 Chronic exercise training also increases Treg cell numbers in circulation. In detail, athletes participating in sports where aerobic capacity is a prominent factor for performance outcome seem to have increased Treg counts. 87, 88 Specific role of exercise during obesity
In case of obesity, exercise training stimulates anti-inflammatory signaling via a reduction in visceral fat mass, which is accompanied by a decrease in the production of several pro-inflammatory adipokines (eg, TNF-α, leptin, retinolbinding protein) and higher levels of adiponectin, which has anti-inflammatory effects and functions as an insulin sensitizer. 89 Current mouse and rat model studies indicate that acute bouts of exercise and exercise training stimulate 
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Exercise and cigarette smoke-induced inflammation phenotypic switching from M1-type macrophages producing TNF, IL-6, and nitric oxide toward M2-type macrophages, which release arginase and anti-inflammatory cytokines. 90, 91 In addition, after exercise training, a reduced tissue expression of ICAM-1, which is involved in the adhesion of inflammatory cells to endothelium and conveys interactions of T cells with target cells, and an inhibition of pro-inflammatory M1-type macrophage migration in adipose tissue occur. 91 
Effects of exercise on pulmonary system after LTCS
Experimental animal studies demonstrated that aerobic exercise after CS exposure or asthma induction reduces lung inflammation 92 and remodeling. 93, 94 In particular, exercise was shown to increase Th1 response and suppress Th2 cytokine levels in lungs of smoke-exposed mice. 95 In parallel, exercise increased antioxidant defense and reduced oxidative stress markers. 96, 97 In CS-exposed mice, it was shown that prior exercise training significantly reduced bronchoalveolar capillary permeability, inflammatory cell infiltration, epithelial thickening, expression of proliferating cell nuclear antigen, mucin 2, cytokines, chemokines, adhesion molecules, and activation of NF-κB. 98 These data proved an important preventive effect of exercise training for smoke-induced inflammation in lung tissue.
Effects of exercise on CS-induced inflammation in blood
Regular exercise training has been shown to lower the levels of several inflammatory, chemoattractive, and coagulative factors in the blood of smoke-exposed mice. However, some human studies and clinical trials also demonstrated that due to dyspnea, COPD patients have restricted activity levels and muscle wasting, a markedly impaired exercise capacity. 99, 100 Therefore, some of these patients develop a kind of exercise intolerance. In this regard, it seems to be important to start exercise programs carefully, because acute and intensive bouts of exercise are known to induce a systemic immunologic response and oxidative stress, which might force inflammation in patients. However, a pro-inflammatory effect of exercise was only shown in muscle-wasted COPD patients after acute and intensive bouts of exercise. Interestingly, this effect was partially blunted by short-term supplementary oxygen. 100, 101 In general, longer periods of regular exercise training show a decrease of many inflammatory cytokines such as TNF-α, IL-2, IL-4, and CRP in COPD patients. 102 Similarly, in murine models, a reduced expression of cell surface markers on circulating immune cells such as vascular adhesion molecule-1 (VCAM-1), ICAM-1, and CD62L was shown after regular treadmill running. Also several other inflammatory cytokines such as IL-1α, MCP-3, MIP-1β, MIP-1α, and CD40L were shown to decrease in smoke-exposed mice after training. 64 In addition, regular endurance exercise has been shown to have favorable effects on blood coagulation by affecting fibrinolysis via decreasing vWF and factor VII. 103 
Effects of exercise on endothelium after LTCS
The effects of CS and exercise on the inflammation of ECs have been well established in the literature. However, to our knowledge, no study has investigated the effects of exercise toward CS-induced inflammation in blood vessels. Therefore, it can only be hypothesized how exercise possibly ameliorates CS-induced inflammation in vessel walls by its effects on inflammation in general.
Endurance exercise training promotes endotheliumdependent vasodilation [104] [105] [106] [107] [108] which is related to a shear stress-induced and Akt-dependent phosphorylation of endothelial NOS, resulting in NO activation. 107 Furthermore, regular physical activity reduces oxidative stress, 108 inflammation, 109, 110 and promotes LDL oxidation. 19 It has also been demonstrated that exercise training has a positive impact on inflammatory markers. Regular physical activity reduced the levels of circulating adhesion molecules 111 like soluble intercellular adhesion molecule-1, 112,113 soluble vascular adhesion molecule-1 (sVCAM-1), 112 soluble P-selectin, and circulating CRP. 109 Prolonged exercise sessions may increase cell adhesion molecules like P-selectin, 113 E-selectin, ICAM-1, and VCAM-1 first, but the endothelium recovers rapidly afterwards. 114 It is noteworthy that the potential influence of exercise training on inflammation, circulating biomarkers, and anti-oxidative capacity depends on exercise capacity. [115] [116] [117] For example, heart failure patients showed reduced endothelial response toward exercise. Indeed, plasma levels of vWF and tPA remained unaffected after exercise while their values increased in healthy subjects. 118, 119 Therefore, endothelial dysfunction and chronic inflammation probably impair exercise capacity. 120 It is therefore crucial that exercise interventions in smokers should be considered as soon as possible since its benefits may decline with the progression of possible diseases.
Effects of exercise on cardiac tissue of smokers
Smoking and physical inactivity are two avoidable risk factors for CVD. 121 As endothelial dysfunction can lead to 
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Madani et al cardiac dysfunction, 122, 123 it is reasonable to assume that protective effects of exercise toward endothelium in (non-) smokers, which are mentioned above, might also be cardioprotective. The decreasing risks for CVDs through moderate exercise training are in part mediated through inducing antiinflammatory factors. [124] [125] [126] [127] Nonetheless, as it was mentioned for vessel walls, studies examining anti-inflammatory effects of exercise in CS-induced inflammation of the myocardium remain poor.
Short-time swimming exercise in CS-exposed Wistar rat could attenuate the impact of CS to the cardiovascular system compared to the control group. 47 Another study with young women demonstrated that even secondhand smoking had a negative influence on exercise capacity due to reduced values of VO 2max and exercise duration and an increased R-to-R value. 129 Exercise intensity rather than duration has a more powerful impact on physiological adaptations regarding inflammation and oxidative stress, 128 like it was described for vessel walls. Even if high-risk patients with severe coronary artery disease or heart failure could benefit the most from more intensive exercise training like high-intensity interval training, its safety has not been properly established. 130 For example, exercise intensity might be a critical factor for the development of exercise-induced hypertension. Increased exercise intensity could trigger more endothelial responses in the absence of inflammatory markers. Therefore, exercise intervention plans should always have to be appropriate to each condition. 23 
Effects of exercise on muscle wasting after LTCS
Exercise is able to reverse sarcopenia and muscle wasting in LTCS by different pathways. On the one hand, a decrease of systemic inflammation and inflammatory mediators in muscle such as TNF-α and IL-1β might indirectly reduce the activation of catabolic pathways and increase anabolic signals. 64 In this regard, exercise has been shown to decrease for FoxO1 phosphorylation and reduce the expression of atrogin-1 and MuRF-1 in skeletal muscle of smoke-exposed mice. Consequently, exercise training abrogates the expression of protein catabolic E3 ligases, which are considered key factors in myofibrillar protein breakdown via the UPS. On the other hand, in particular, resistance training is also known to directly increase IGF-1 signaling followed by the activation of the Akt-mTOR-pathway. 131, 132 The reduction of catabolic and stimulation of anabolic signaling attenuate or reverse muscle wasting after smoke exposure. Endurance training was also shown to increase metabolic capacities of muscles by increased expression of genes involved in fatty acid transport into the mitochondrial matrix. Similarly, glucose uptake was optimized after regular exercise training. 64 The differentiated effects of exercise training on muscle tissue might also depend on the mode of exercise. While endurance training more efficiently addresses type I fibers and oxidative metabolism, strength or resistance training mainly affects type II fibers, induces hypertrophy, and increases strength capabilities. However, most pulmonary rehabilitation programs include both endurance and resistance exercise to maximize gains from both modalities. Alternatively, it has been shown that combined training program which includes both resistance and endurance exercise modalities increases strength and endurance in COPD patients. 133 Effects of exercise on brain after LCTS Inflammation and vascular-induced abnormalities in the brain are two conditions associated with stroke and other neurovascular diseases, which can be protected by regular physical activity in humans. 134 In humans and animals, exercise upregulates brain neurotrophin and brain-derived neurotophin factor (BDNF), which is an important factor of neuronal function, growth, and survival. BDNF increases the brain's resistance to damage and degeneration. 135 The immediate response of the brain to acute exercise produces only marginal changes of inflammatory mediators. 136 On the other hand, regular physical activity improves the overall immune condition in the brain. 137 Murine studies proved that pro-inflammatory cytokines impair the IGF-1 signal transduction in neurons. Peripheral IGF-1 is essential in glucose metabolism and cerebrovascular function. One mechanism by which the negative effects of inflammation are counteracted by exercise is the restoration of IGF-1 signaling. 137 In a study with mice, endurance and strength training decreased most of the inflammatory factors, such as IL-1α, IL-2, and IL-18. Interestingly, NF-κB and COX-2 protein levels were significantly increased probably due to circulating IL-6 after training. The increased expression of COX-2 and microsomal prostaglandin E synthase, an enzyme downstream of COX-2, were independent of peripheral inflammation. 138 Exercise improved oxidative stress and inflammation directly at the brain of old high-fat-fed ApoE −/− mice, reaffirming the neuroprotective effects of exercise in a model of mice with vascular brain lesions. 138 On the other hand, aged mice, training above the lactate threshold showed increased levels of brain PGC-1α, mTOR, and phospho-mTOR protein levels, as well as citrate synthase mRNA levels. 139 A similar relationship has 
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Exercise and cigarette smoke-induced inflammation been confirmed in young mice. 140 In addition, for FOXO-3 translocated from the nucleus to the cytoplasm, predicting an increased and facilitated VEGF-A expression. 141 Another study using rats in a traumatic brain injury model showed that aerobic exercise training enhances the endogenous anti-inflammatory response (IL-10), inhibits the infiltration of neutrophils, and attenuates BBB breakdown as well as pro-inflammatory cytokines (IL-1β, TNFα). 141 
Neuroprotective effects of exercise
Neuroprotective and anti-inflammatory effects of exercise on the brain have also been shown in humans. Moderate intensity interval training in Parkinson's disease patients attenuated inflammation by decreasing circulating sVCAM-1 and serum TNF-α and increasing serum BDNF levels. 142 Accordingly, exercise training has the potential to be a new therapeutic approach to control acute inflammation. 143 These effects remain to be proven in response to CS-induced inflammation. So far, only one study has investigated the effects of exercise training on CS-exposed brain oxidative stress. 144 Mice exposed to CS showed decreased levels of BDNF and higher immobility in a forced swim test. Exercise was able to prevent oxidative damage, but surprisingly, it could neither reverse the decrease of BDNF nor it was able to prevent CS-induced depressive-like behavior. 144 These results clearly show that molecular effects of exercise on CS-induced inflammation at the brain needs to be investigated in future research projects.
Conclusion
Taken together, LTCS induces local and systemic inflammatory processes which might be mediated directly by pollutant particles and a spillover of inflammatory signals to other tissues. These inflammatory processes might induce or amplify signals of tissue degradation and catabolic processes. Exercise training has been shown to prevent and even reverse inflammatory processes leading to reduced tissue degradation and catabolic processes. In parallel, exercise elicits anabolic signals leading to an increased functional capacity. Accordingly, regular exercise training seems to protect long-term smokers against some important negative local and systemic consequences of smoking. In this regard, the immune-regulating properties of exercise might have relevance (Figure 2 ). It has to be considered that many molecular findings from smoking or exercise effects on tissues were obtained from animal studies, and this knowledge has to be only carefully transferred to humans. 
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More studies are needed to discover the mechanisms how exercise affects inflammation in smokers. Specifically, the effects of exercise on inflammation in various organs in smokers have to be confirmed. From a clinical point of view, data suggest that it seems to be important to start exercise training as early as possible for smokers. In this regard, the progressive increase of certain inflammatory signals might be important predictors of the necessity of starting a regular exercise training program.
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